That's too dangerous imo. They should not be relying upon the FDA before securing funding of some sort to at least get us through until well into next year. Blowing $27mn on the close out costs has put us in a perilous position. Any delays and we are severely compromised.
Perhaps what FB mentioned about forward selling royalties will come to fruition. I really don't like the sound of it but beggars can't be choosers.
They seem determined to take the prime asset (Europe/US) as far as possible before dealing. I hope this isn't our downfall.
Where we at?, page-93
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 21.5¢ | $288.5K | 1.279M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 130626 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |